GBA1 and Parkinson disease: Similar changes are seen in the SN and hippocampus of sporadic PD patients without GBA1 mutations [58], along with a reduction in the activity of GCase, α-mannosidase, β-mannosidase, and β-hexosaminidase in the cerebrospinal fluid of PD patients [59].